Dr Peter Schulz-Knappe indicates that autoimmune diseases now represents the 2nd main area of focuss of research after cancer area. However autoimmune diseases are underserved in terms of diagnostic testing and drugs. Dr Schulz-Knappe presents strategies to discover new biomarkers for autoimmune diseases.
